Responding to the opioid crisis in North America and beyond: recommendations of the Stanford–Lancet Commission

K Humphreys, CL Shover, CM Andrews, ASB Bohnert… - The Lancet, 2022 - thelancet.com
Executive summary The Stanford–Lancet Commission on the North American Opioid Crisis
was formed in response to soaring opioid-related morbidity and mortality in the USA and …

Scoping review of mental health in prisons through the COVID-19 pandemic

L Johnson, K Gutridge, J Parkes, A Roy, E Plugge - BMJ open, 2021 - bmjopen.bmj.com
Objective To examine the extent, nature and quality of literature on the impact of the COVID-
19 pandemic on the mental health of imprisoned people and prison staff. Design Scoping …

Substance, use in relation to COVID-19: a scoping review

N Kumar, K Janmohamed, K Nyhan, SS Martins… - Addictive …, 2022 - Elsevier
Background We conducted a scoping review focused on various forms of substance use
amid the pandemic, looking at both the impact of substance use on COVID-19 infection …

The health impacts of the COVID-19 pandemic on adults who experience imprisonment globally: A mixed methods systematic review

H Kim, E Hughes, A Cavanagh, E Norris, A Gao… - PloS one, 2022 - journals.plos.org
Background The prison setting and health status of people who experience imprisonment
increase the risks of COVID-19 infection and sequelae, and other health impacts of the …

Pathways between COVID-19 public health responses and increasing overdose risks: A rapid review and conceptual framework

T Nguyen, JA Buxton - International journal of drug policy, 2021 - Elsevier
Background Emerging evidence indicates that illicit drug overdoses are increasing
throughout the COVID-19 pandemic. There is a paucity of evidence on the causative …

Nothing really changed: Arizona patient experience of methadone and buprenorphine access during COVID

BE Meyerson, KG Bentele, DM Russell, BR Brady… - PLoS …, 2022 - journals.plos.org
Objective To understand patient experience of federal regulatory changes governing
methadone and buprenorphine (MOUD) access in Arizona during the COVID-19 pandemic …

COVID-19 in the California state prison system: an observational study of decarceration, ongoing risks, and risk factors

ET Chin, T Ryckman, L Prince, D Leidner… - Journal of general …, 2021 - Springer
Background Correctional institutions nationwide are seeking to mitigate COVID-19-related
risks. Objective To quantify changes to California's prison population since the pandemic …

COVID-19 in carceral systems: a review

LB Puglisi, L Brinkley-Rubinstein… - Annual Review of …, 2023 - annualreviews.org
As with past pandemics of influenza, COVID-19 tore through US prisons and jails; however,
the COVID-19 pandemic, uniquely, has led to more health research on carceral systems …

Illicit substance use and the COVID-19 pandemic in the United States: a scoping review and characterization of research evidence in unprecedented times

AT Vo, T Patton, A Peacock, S Larney… - International journal of …, 2022 - mdpi.com
We carried out a scoping review to characterize the primary quantitative evidence
addressing changes in key individual/structural determinants of substance use risks and …

Methadone and buprenorphine treatment in United States jails and prisons: lessons from early adopters

S Bandara, A Kennedy‐Hendricks, S Merritt… - …, 2021 - Wiley Online Library
Aims To identify implementation barriers and facilitators to the adoption and implementation
of programs that provide opioid agonist treatments (OAT) with methadone and …